Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/124013
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Suarez Lledó, A. | - |
dc.contributor.author | Padullés Zamora, Ariadna | - |
dc.contributor.author | Lozano, T. | - |
dc.contributor.author | Cobo Sacristán, Sara | - |
dc.contributor.author | Colls González, Montserrat | - |
dc.contributor.author | Jódar Masanés, Ramón José | - |
dc.date.accessioned | 2018-07-27T10:43:31Z | - |
dc.date.available | 2018-07-27T10:43:31Z | - |
dc.date.issued | 2018-02-13 | - |
dc.identifier.uri | http://hdl.handle.net/2445/124013 | - |
dc.description.abstract | Most drugs that act on the central nervous system (CNS) require dose titration to avoid withdrawal syndrome. Tizanidine withdrawal syndrome is caused by adrenergic discharge due to its alpha(2)-agonist mechanism and is characterized by hypertension, reflex tachycardia, hypertonicity, and anxiety. Although tizanidine withdrawal syndrome is mentioned as a potential side effect of cessation, it is not common and there have been few reports. We present the case of a 31-year-old woman with tizanidine withdrawal syndrome after discontinuing medication prescribed for a muscle contracture (tizanidine). She showed high adrenergic activity with nausea, vomiting, generalized tremor, dysthermia, hypertension, and tachycardia. Symptoms were reversed and successful reweaning was achieved by restarting tizanidine followed by slow downward titration. Withdrawal syndrome should be considered when drugs targeting the CNS are suddenly stopped. Weaning regimens should be closely monitored for acute withdrawal reactions. | - |
dc.format.extent | 3 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Sage Publications | - |
dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.1177/1179547618758022 | - |
dc.relation.ispartof | Clinical Medicine Insights: Case Reports, 2018, vol. 11 | - |
dc.relation.uri | http://dx.doi.org/10.1177/1179547618758022 | - |
dc.rights | cc by-nc (c) Sage, 2018 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/es/ | - |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Síndrome d'abstinència | - |
dc.subject.classification | Hipertensió | - |
dc.subject.other | Drug withdrawal symptoms | - |
dc.subject.other | Hypertension | - |
dc.title | Management Of Tizanidine Withdrawal Syndrome: A Case Report | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2018-07-24T11:47:51Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 29467587 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1179547618758022.pdf | 98.36 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License